Concord Biotech is pleased to announce the successful completion of @anvisa_oficial inspection conducted by the Brazilian Health Regulatory Agency at our Unit-III API Manufacturing Facility in Limbasi from 8–12 June 2026. #ANVISA #Brazil #RegulatoryExcellence #APIManufacturing

Choosing the right API intermediate manufacturing partner isn't just about sourcing a chemical—it's about securing your supply chain, ensuring regulatory success, and scaling efficiently. #APIManufacturing #PharmaIntermediates #GMPCompliance #PYGLifescences #MakeInIndia

This World Environment Day, our Chairman, Mr. C. C. Paarthipan, inspired employees with his address and led a sapling plantation initiative at our Sterile Manufacturing Facility, Gummidipoondi, reinforcing our shared commitment to nurturing a greener and more sustainable tomorrow. #caplinpointlaboratories #caplinpoint #caplinsteriles #caplinonelabs #caplinone #sterilemanufacturing #pharmamanufacturing #pharma #pharmaceuticals #injectables #formulations #RandD #environment #environmentday #worldenvironmentday #caplinwishes #solidorals #API #APImanufacturing #cancertreatment #oncology #affordablehealthcareforall #affordablecancercare

IOLCP revenue rises 11.5% YoY to Rs. 2,319.1 crore in FY26 indianpharmapost.com/news/io… #IOLCP #Chemicals #Pharmaceuticals #APIManufacturing #Non-Ibuprofen @indpharmapost

Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Foscarnet Sodium Injection (6000 mg/250 mL Infusion Bag), a generic therapeutic equivalent version of the Reference Listed Drug (RLD) Foscavir Injection from Clinigen Healthcare Ltd. Foscarnet Sodium Injection is an antiviral medication used to treat CMV retinitis in AIDS patients and HSV infection in immunocompromised individuals. According to IQVIATM (IMS Health), Foscarnet Sodium Injection, (6000 mg/250 mL Infusion Bag) had US sales of approximately $15 million for the 12-month period ending March 2026. Click on the Link for Press Release : caplinpoint.net/wp-content/u… #ANDA #caplinpointlaboratories #caplinpoint #caplinsteriles #caplinone #caplinsterilesUSA #CPL #CSL #COL #CSU #caplinonelabs #caplinapprovals #sterilemanufacturing #pharmamanufacturing #injectables #formulations #steriles #RandD #solidorals #cancertreatment #oncology #API #APImanufacturing #foscarnetsodiuminjection #foscarnetsodium #vials #injection #WeChooseToBeDifferent #AffordableHealthcareforAll

Caplin Point Laboratories Ltd announced its consolidated financial results for Q4 & FY26. A few key highlights from the results. Read the detailed report here : caplinpoint.net/wp-content/u… #caplinpointlaboratories #caplinone #caplin #caplinonelabs #caplinsteriles #sterilemanufacturing #injectables #FY26results #Q4nFY26results #Q4FY26 #Q4 #FY26 #Q4results #formulation #solidorals #financialresults #caplinpoint #pharmamanufacturing #caplinfinancials #Q4financials #annualresults #financials #cancertreatment #oncology #API #APImanufacturing #WeChoosetobeDifferent #AffordableHealthcareforAll

Hydrogenation reactors for modern API manufacturing—focused on the right fit for your process & GMP needs. #EKATO #MixingSolution #Hydrogenation #APIManufacturing #PharmaEngineering #Pharma #ProcessEngineering #GMPCompliance Read more: chemengonline.com/partner-co…

Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Calcium Gluconate Injection USP (100 mg/mL in 10 mL, 50 mL and 100 mL Vials), a generic therapeutic equivalent version of the Reference Listed Drug (RLD) from Fresenius Kabi USA, LLC. Calcium Gluconate Injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. According to IQVIATM (IMS Health), Calcium Gluconate Injection USP, (100 mg/mL in 10 mL, 50 mL and 100 mL Vials) had US sales of approximately $71 million for the 12-month period ending March 2026. Click on the Link for Press Release : caplinpoint.net/wp-content/u… #ANDA #caplinpointlaboratories #caplinpoint #caplinsteriles #caplinone #caplinsterilesUSA #CPL #CSL #COL #CSU #caplinonelabs #caplinapprovals #sterilemanufacturing #pharmamanufacturing #injectables #formulations #steriles #RandD #solidorals #cancertreatment #oncology #API #APImanufacturing #calciumgluconate #calciumgluconateinjection #vials #injection #WeChooseToBeDifferent #AffordableHealthcareforAll

Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Potassium Phosphates Injection USP, (phosphorus 3 mmol/mL and potassium 4.4 mEq/mL in 5 mL, 15 mL and 50 mL Vials), a generic therapeutic equivalent version of the Reference Listed Drug (RLD) from Fresenius Kabi USA, LLC. Potassium Phosphates Injection is used as a source of phosphorus in intravenous fluids to correct hypophosphatemia and as parenteral nutrition in adults and pediatric patients, who cannot take oral supplements. According to IQVIATM (IMS Health), Potassium Phosphates injection USP, (phosphorus 3 mmol/mL and potassium 4.4 mEq/mL in 5 mL, 15 mL and 50 mL Vials) had US sales of approximately $57 million for the 12-month period ending January 2026. Click on the Link for Press Release : caplinpoint.net/wp-content/u… #ANDA #caplinpointlaboratories #caplinpoint #caplinsteriles #caplinone #caplinsterilesUSA #CPL #CSL #COL #CSU #caplinonelabs #caplinapprovals #sterilemanufacturing #pharmamanufacturing #injectables #formulations #steriles #RandD #solidorals #cancertreatment #oncology #API #APImanufacturing #potassiumphosphates #potassiumphosphatesinjection #vials #injection #WeChooseToBeDifferent #AffordableHealthcareforAll

Madhya Pradesh continues to strengthen its pharmaceutical manufacturing ecosystem with the presence of 30 API and Bulk Drug manufacturers across the state. With strong industrial infrastructure, strategic connectivity, supportive policies, and a growing pharma base, the state is playing a critical role in reinforcing India’s API supply chain resilience. For investors and industry leaders, Madhya Pradesh offers scalability, operational efficiency, and long-term growth potential across the pharmaceutical value chain. Connect with MPIDC to explore investment opportunities. Visit: sws.invest.mp.gov.in/ #MPIDC #MadhyaPradesh #APIManufacturing #BulkDrugs #PharmaIndustry #InvestMP #IndustrialGrowth #MakeInIndia

At the Uttar Pradesh Pharma Conclave 1.0, we are honoured to welcome Shri Ayodhya Rami Reddy A, Chairman, Ramky Group and Hon’ble Member of Rajya Sabha. A visionary leader in infrastructure, life sciences, and globally compliant API manufacturing, Ramky Group brings world-class expertise and innovation to strengthen India’s pharmaceutical ecosystem. His presence marks a significant step toward advancing sustainable pharma growth, fostering global standards, and accelerating Uttar Pradesh’s emergence as a leading pharma hub. Join us on 3rd February 2026 at Hotel Taj Mahal, Lucknow, and be part of this transformative journey shaping the future of India’s pharma industry. #UPPharmaConclave #PharmaFuture #RamkyGroup #APIManufacturing #LifeSciences #UttarPradesh #PharmaLeadership #MakeInIndia #HealthcareInnovation #PharmaGrowth

Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Methylprednisolone Acetate Injectable Suspension USP, 40mg/mL & 80mg/mL Single Dose vials, a generic therapeutic equivalent version of the Reference Listed Drug (RLD) DEPO-MEDROL from Pfizer Inc., USA. Methylprednisolone Acetate Injectable Suspension is primarily used as an anti-inflammatory treatment in various conditions, including in allergic states, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematologic diseases, ophthalmic diseases, respiratory diseases, rheumatic disorders etc. According to IQVIATM (IMS Health), Methylprednisolone Acetate Injectable Suspension USP, 40mg/mL & 80mg/mL Single Dose vials had US sales of approximately $57.4 million for the 12-month period ending November 2025. Click on the Link for Press Release : caplinpoint.net/wp-content/u… #ANDA #caplinpointlaboratories #caplinpoint #caplinsteriles #caplinone #caplinsterilesUSA #CPL #CSL #COL #CSU #caplinonelabs #caplinapprovals #sterilemanufacturing #pharmamanufacturing #injectables #formulations #steriles #RandD #solidorals #cancertreatment #oncology #API #APImanufacturing #methylprednisoloneacetate #methylprednisolone #vials #injectablesuspension #injection #WeChooseToBeDifferent #AffordableHealthcareforAll

The Caplin family came together across locations to celebrate the harvesting season. May this harvesting season bring you health and happiness in abundance. Caplin wishes everyone a happy Pongal. #caplinpointlaboratories #caplinpoint #caplinsteriles #caplinonelabs #caplinone #sterilemanufacturing #pharmamanufacturing #pharma #pharmaceuticals #injectables #formulations #RandD #pongal #makarsankranthi #lohri #bihu #caplinwishes #solidorals #cancertreatment #oncology #API #APImanufacturing #affordablehealthcareforall #affordablecancercare

We’re pleased to share that our new API manufacturing unit has commenced operations, which will be a key part of our long-term backward integration strategy. The primary objective is to strengthen supply chain robustness for our own formulations—improving control, reliability, and risk diversification across key molecules. Beyond internal needs, this unit is being built with an agile, execution-focused mindset, aimed at supporting partners who value speed, flexibility, and hands-on problem solving. We’re keen to engage with companies looking for a small, technically strong API team that can move quickly, adapt pragmatically, and deliver without layers of complexity—whether for early-stage development, scale-up support, or niche CDMO requirements. Looking forward to meaningful collaborations where execution and accountability matter. #caplinpointlaboratories #caplinpoint #caplinsteriles #caplinone #CPL #CSL #COL #caplin #APImanufacturing #API #sterilemanufacturing #pharmamanufacturing #injectables #formulations #steriles #RandD #WeChooseToBeDifferent #AffordableHealthcareforAll

API & Biosimilar QC/R&D experts: Hands-on NMR Data Acquisition Workshop. Industry participants only. Strictly 10 seats. Investment: ₹1.5L GST Apply now! cce.iisc.ac.in/self-support-… #NMRSpectroscopy #Pharma #biotech #IISc #APIManufacturing #Biosimilars #QC #RND

API & Biosimilar QC/R&D experts: Hands-on NMR Data Acquisition Workshop. Industry participants only. Strictly 10 seats. Investment: ₹1.5L GST Apply now! cce.iisc.ac.in/self-support-… #NMRSpectroscopy #Pharma #biotech #IISc #APIManufacturing #Biosimilars #QC #RND

Neuland Labs Skyrockets: Q2 PAT Jumps 195% to ₹97 Cr on 65% Revenue Surge! Like | Share | Follow | Comment For Daily Updates. capitalmarket.com #NeulandLabs #Q2Results #StockMarketIndia #PATSurge #EarningsReport #PharmaStock #APIManufacturing #FinancialGrowth #StockGains #IndianPharma #ProfitJump #RevenueGrowth #BSE #NSE #MidcapStocks #InvestingNews #QuarterlyResults #FY26 #CorporateFinance

IOL Chemicals & Pharmaceuticals Ltd To Invest Rs 1,400 Crore in Punjab: Sanjeev Arora yespunjab.com/?p=176285 #PunjabNews #IOLChemicals #APIManufacturing #BarnalaProject #PharmaIndustry #EmploymentInPunjab #BhagwantSinghMann #SanjeevArora #IndustrialGrowth #GreenfieldInvestment #PunjabDevelopment

#LupinInNews: Lupin announced that the API manufacturing facility of its wholly owned subsidiary, Lupin Manufacturing Solutions (LMS), in Dabhasa, Gujarat, has received the Good Manufacturing Practice (GMP) certification from the Therapeutic Goods Administration (TGA), Australia's medicines and medical devices regulator. Read More: bit.ly/3U5uEcZ #Lupin #TGACertification #GMPCertified #APImanufacturing #HealthcareInnovation #LupinInNews

🚨 LINCOLN PHARMA EXPANSION UPDATE ✅ Trial run for new API facility completed ✅ Commercial production to start in 1–2 years ✅ Investment: ₹4 Cr | Capacity: 1.2 TPA ✅ Market sentiment: Positive #PharmaStocks #LincolnPharma #APIManufacturing #StockMarketIndia